Years ago, when I worked on a communications campaign for a cardiovascular product, I advised the team to...
ESG in the Biopharma Industry: Do Well By Doing Good
The biopharma industry suffers from an image problem. Exorbitant drug prices, out-of-control healthcare costs, and the opioid crisis...
New NET Cancer Therapy Reshapes Treatment Landscape
NET cancer — or neuroendocrine tumor cancer — isn’t well known. It isn’t branded by the color pink...
Recruiting Patients for Clinical Trials Remains a Tough Challenge
When I first started working in the biopharmaceutical industry, recruiting patients into clinical trials was difficult. I remember...
Medical Writers Excel at More Than Just Writing
Medical writers in the biopharmaceutical industry write and edit regulatory documents that support the development and approval of...
Hypoparathyroidism: Communicating the Patient Journey for this Rare Disease
In support of World Hypoparathyroidism Awareness Day 2020, I worked with a biopharmaceutical client and the HypoPARAthyroidism Association...
Inspiring a New Generation of Women in Diabetes Research
For this article, I had the honor of interviewing two distinguished women scientists whose innovative ideas, tenacity, and...
Neuroendocrine Tumor Cancer: Kept at Bay for Six Years
An unwelcome visitor knocked on our door six years ago this month. Despite our protestations, the visitor chose...